| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Chief Operating Officer
1 company
Patel Anish is a Chief Operating Officer at Enliven Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $9.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 8, 2024 | ELVN Enliven Therapeutics, Inc. | Chief Operating Officer | Sell | 4,875 | $18.60 | $90,686.79 | -45.9% | +22.7% | -13.6% | |
| Mar 6, 2024 | ELVN Enliven Therapeutics, Inc. | Chief Operating Officer | Sell | 4,875 | $15.64 | $76,238.66 | -39.5% | +35.5% | +38.9% | |
| Feb 6, 2024 | ELVN Enliven Therapeutics, Inc. | Chief Operating Officer | Sell | 4,875 | $15.11 | $73,658.33 | -28.3% | +45.7% | +44.6% | |
| Jan 22, 2024 | ELVN Enliven Therapeutics, Inc. | Chief Operating Officer | Sell | 4,875 | $15.14 | $73,783.13 | -22.1% | +19.6% | +49.4% | |
| Jan 2, 2024 | ELVN Enliven Therapeutics, Inc. | Chief Operating Officer | Sell | 13,540 | $15.02 | $203,348.35 | -13.3% | +26.8% | +60.4% | |
| Dec 26, 2023 | ELVN Enliven Therapeutics, Inc. | Chief Operating Officer | Sell | 1,085 | $15.03 | $16,306.28 | -1.5% | +22.7% | +56.7% |